Skip to main content
. Author manuscript; available in PMC: 2014 Sep 18.
Published in final edited form as: Pediatr Pulmonol. 2011 Sep 8;47(3):252–263. doi: 10.1002/ppul.21546

Figure 1.

Figure 1

Height Standard Deviation Score (SDS) by visit (as randomized subjects), measured in pre-pubertal CF children at each study visit, for the rhGH study group and control group. There was no significant increase in the height SDS of the control group from baseline to the 12-month visit (Hochberg-adjusted p = 0.8904). The rhGH group demonstrated a significant increase in height SDS from baseline to the 12-month visit (Hochberg-adjusted p < 0.0001). Additionally, the change from baseline to the 12-month visit was significantly greater for rhGH-treated subjects compared with the control subjects (p < 0.001). Hochberg-adjusted p values for changes from Month 12 to Month 18: Control p = 0.7007 and rhGH p = −0.0027. Error bars represent standard deviations.